In the RIP-LCMV-NP mice the incidence of diabetes in JAM-C antibody-treated mice was slightly delayed and reduced to 61% compared to an incidence of 76% in control mice (Figure 3B). This evidence concerns the gene JAM3 and diabetes mellitus.